Your browser doesn't support javascript.
loading
節目: 20 | 50 | 100
结果 1 - 2 de 2
过滤器
添加過濾器








研究类型
年份範圍
1.
Asian Spine Journal ; : 870-879, 2017.
文章 在 英语 | WPRIM | ID: wpr-102662

摘要

STUDY DESIGN: We established induced pluripotent stem cells (iPSCs) and neural stem/progenitor cells (NSPCs) from three newborns with spina bifida aperta (SBa) using clinically practical methods. PURPOSE: We aimed to develop stem cell lines derived from newborns with SBa for future therapeutic use. OVERVIEW OF LITERATURE: SBa is a common congenital spinal cord abnormality that causes defects in neurological and urological functions. Stem cell transplantation therapies are predicted to provide beneficial effects for patients with SBa. However, the availability of appropriate cell sources is inadequate for clinical use because of their limited accessibility and expandability, as well as ethical issues. METHODS: Fibroblast cultures were established from small fragments of skin obtained from newborns with SBa during SBa repair surgery. The cultured cells were transfected with episomal plasmid vectors encoding reprogramming factors necessary for generating iPSCs. These cells were then differentiated into NSPCs by chemical compound treatment, and NSPCs were expanded using neurosphere technology. RESULTS: We successfully generated iPSC lines from the neonatal dermal fibroblasts of three newborns with SBa. We confirmed that these lines exhibited the characteristics of human pluripotent stem cells. We successfully generated NSPCs from all SBa newborn-derived iPSCs with a combination of neural induction and neurosphere technology. CONCLUSIONS: We successfully generated iPSCs and iPSC-NSPCs from surgical samples obtained from newborns with SBa with the goal of future clinical use in patients with SBa.


Subject(s)
Humans , Infant, Newborn , Cells, Cultured , Ethics , Fibroblasts , Induced Pluripotent Stem Cells , Meningomyelocele , Plasmids , Pluripotent Stem Cells , Regenerative Medicine , Skin , Spina Bifida Cystica , Spinal Cord , Spinal Dysraphism , Stem Cell Transplantation , Stem Cells
2.
Asian Journal of Andrology ; (6): 549-554, 2006.
文章 在 英语 | WPRIM | ID: wpr-253826

摘要

<p><b>AIM</b>To identify proteins induced by androgen in Sertoli cells during spermatogenesis.</p><p><b>METHODS</b>We analyzed protein profiles in TM4 Sertoli cells treated with dihydrotestosterone (DHT) using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).</p><p><b>RESULTS</b>We found increases in the expression of a 5.0-kDa protein at 15 min, an 11.3-kDa protein at 24 h and 4.3 kDa, 5.7 kDa, 5.8 kDa, 9.95 kDa and 9.98 kDa proteins at 48 h after the treatment. In contrast, the expression of 6.3 kDa and 8.6 kDa proteins decreased at 30 min, and 4.9 kDa, 5.0 kDa, 12.4 kDa and 19.8 kDa proteins at 48 h after the treatment. The 11.3-kDa protein was identified as macrophage migration inhibitory factor (MIF) known to having various functions. The 9.98-kDa protein was identified as calgizzarin related to calcium channels. The timing of their expression suggests that MIF and calgizzarin are involved in late regulation of spermatogenesis in Sertoli cells by androgen.</p><p><b>CONCLUSION</b>MIF and calgizzarin are two important androgen-responsive proteins produced by Sertoli cells and they might play a role in regulating spermatogenesis.</p>


Subject(s)
Animals , Male , Mice , Androgens , Pharmacology , Cell Line , Dihydrotestosterone , Pharmacology , Gene Expression Regulation , Kinetics , Macrophage Migration-Inhibitory Factors , Genetics , Protein Array Analysis , S100 Proteins , Genetics , Sertoli Cells , Physiology , Spermatogenesis
搜索明细